As of August 28, 2026, Balance Labs, Inc. (BLNC) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Balance Labs, Inc. has a market capitalization of $72.62M, 46.85M shares outstanding. Stored dilution-related fields include 40.0K outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 33%
🔄 Reverse Split
model est. 45%
• 50-day avg $1.55 approaching $1 threshold
• Only 6 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 6 months remaining
Market Data
Market Cap$72.62M
Shares Outstanding46.85M
Float33.71M
Cash$126.8K
Debt$25.0K
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest1
Days to Cover1000.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
xbrl
XBRL WARRANT
2025-09-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual BLNC Dilution Snapshot
Balance Labs, Inc. (BLNC) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for BLNC: xbrl on 2025-12-31; xbrl on 2025-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track BLNC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLNC — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required